Anxiety Disorder In General Practice Research Articles

Recognition of anxiety disorders in children: a cross-sectional vignette-based survey among general practitioners

ObjectiveTo quantify general practitioners’ (GPs) sensitivity to anxiety disorders (ADs) when confronted with the range of symptoms common to children with ADs. Also, to explore GPs’ conscious preferences and implicit...

Collaborative care vs consultation liaison for depression and anxiety disorders in general practice: study protocol for two randomized controlled trials (the Danish Collabri Flex trials)

BackgroundModels of collaborative care and consultation liaison propose organizational changes to improve the quality of care for people with common mental disorders, such as anxiety and depression. Some literature suggests only short-term positive effects of consultation liaison on patient-related outcomes, whereas collaborative care demonstrates both short-term and long-term positive effects. To our knowledge, only one randomized trial has compared the effects of these models. Collaborative care was superior to consultation liaison in reducing symptoms of depression for up to 3 months, but the authors found no difference at 9-months' follow-up. The Collabri Flex Trial for Depression and the Collabri Flex Trial for Anxiety aim to compare the effects of collaborative care with those of a form of consultation liaison that contains potential contaminating elements from collaborative care. The trials build on knowledge from the previous cluster-randomized Collabri trials.MethodsTwo randomized, investigator-initiated, parallel-group, superiority trials have been established: one investigating the effects of collaborative care vs consultation liaison for depression and one investigating the effects of collaborative care vs consultation liaison for generalized anxiety, panic disorder and social anxiety disorder at 6-months' follow-up. Participants are recruited from general practices in the Capital Region of Denmark: 240 in the depression trial and 284 in the anxiety trial. The primary outcome is self-reported depression symptoms (Beck Depression Inventory (BDI-II)) in the depression trial and self-reported anxiety symptoms (Beck Anxiety Inventory (BAI)) in the anxiety trial. In both trials, the self-reported secondary outcomes are general psychological problems and symptoms (Symptom Checklist 90-Revised), functional impairment (Sheehan Disability Scale) and general well-being (World Health Organization-Five Well-Being Index). In the depression trial, BAI is an additional secondary outcome, and BDI-II is an additional secondary outcome in the anxiety trial. Explorative outcomes will also be collected.DiscussionThe results will supplement those of the cluster-randomized Collabri trials and provide pivotal information about the effects of collaborative care in Denmark.Trial registrationClinicalTrials.gov, NCT03113175 and NCT03113201. Registered on 13 April 2017.

Anxiety Disorders in General Practice

Anxiety disorders are a variant of borderline mental pathology belonging to the group of neurotic disorders, that is, to psychogenically caused by painful conditions characterized by a variety of clinical manifestations. Timely diagnosis and early start of adequate treatment of anxiety spectrum disorders can significantly improve the quality of life of patients.The article discusses the phenomenological aspects of anxiety disorders, especially the diagnosis and treatment in the general medical network, in particular, the currently recommended regimens for using the drug Eglonil and the advantages of this drug are described. Eglonil demonstrates the possibility of widespread use in various types of anxiety disorders, which gives the drug a special status among other psychotropic compounds.

Patterns of healthcare utilization in patients with generalized anxiety disorder in general practice in Germany

Patterns of healthcare utilization in patients with generalized anxiety disorder in general practice in Germany

Prevalence of Generalized Anxiety Disorder in General Practice in Denmark, Finland, Norway, and Sweden

Prevalence of Generalized Anxiety Disorder in General Practice in Denmark, Finland, Norway, and Sweden

Prevalence of Generalized Anxiety Disorder in General Practice in Denmark, Finland, Norway, and Sweden

Prevalence of Generalized Anxiety Disorder in General Practice in Denmark, Finland, Norway, and Sweden

Prevalence of Generalized Anxiety Disorder in General Practice in Denmark, Finland, Norway, and Sweden

This study assessed the prevalence rate of generalized anxiety disorder among patients of general practitioners in Denmark, Finland, Norway, and Sweden and determined whether general practitioners recognize the condition and its correlates. Data were gathered in September 2001. Participating patients received a questionnaire that included the Generalized Anxiety Questionnaire and the Depression Screening Questionnaire. The scale used DSM-IV criteria to identify generalized anxiety disorder and major depressive episode. General practitioners filled in a questionnaire about their patients' mental and physical illnesses, including generalized anxiety and major depressive episode. General practitioners' basic sociodemographic data and professional career information were also gathered. A total of 648 general practitioners and 8,879 patients participated in the study. The age-standardized rates for generalized anxiety disorder ranged from 4.1 to 6.0 percent for males and from 3.7 to 7.1 percent for females; for major depressive episode the rates ranged from 7.2 to 11.5 percent for males and from 9.9 to 14.2 percent for females. The proportion of generalized anxiety disorder cases recognized by general practitioners varied from 33 percent in Denmark to 53 percent in Norway. Recognition of generalized anxiety disorder by general practitioners was associated with presentation of anxiety problems by the patients. Physical symptoms as a reason for a consultation was associated with lowered recognition of generalized anxiety disorder. Previous diagnoses of generalized anxiety disorder or anxiety neurosis were associated with increased recognition of generalized anxiety disorder. Of the total percentage of cases of generalized anxiety disorder in general practice (4.8 percent for males and 6.0 percent for females), only one-third to one-half of the cases were identified by the general practitioners.

The Role of Symptoms in the Recognition of Mental Health Disorders in Primary Care

This study investigates the role of patients' complaints and symptoms in the diagnostic process of mood and anxiety disorders in general practice. In 12 primary care practices, 1,211 patients were diagnosed with the aid of the National Institute of Mental Health Diagnostic Interview Schedule, then the diagnoses were compared with those established by the general practitioners. A low rate of concordance was found between these diagnoses. The absence of somatic illnesses and the presence of psychological complaints were the most important factors in the recognition of a mental illness by the general practitioners. The concordance between the general practitioners and the DIS diagnoses was higher if the patients had neither an acute nor a chronic somatic illness.